Archives

The 6th Global Forum on TB Vaccines will take place from 20 – 22 April 2021 in France at the Centre Pierre Baudis in Toulouse. Please read the announcement of the Global Forum 2021.

The final programme of the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” is available. The TBVI meeting will be held in Les Diablerets, Switzerland from [...]

Thanks to H2020 investments substantial progress has been made in the innovation and development of vaccines against TB. This is shown by the promising results of three H2020-funded TB vaccine [...]

The publication preferred product characteristics (PPC) for therapeutic TB vaccines provides guidance to scientists, funding agencies, public and private sector organizations developing such [...]

TBVI is pleased to announce the TBVI meeting “Accelerating the TB vaccine pipeline – towards Horizon Europe” in Les Diablerets. The meeting will be held from 27th to 29th of January [...]

The Tuberculosis Vaccine Initiative (TBVI) and IAVI have recently updated and expanded the TB Vaccine Development Pathway, a methodology and tool that provides a structured development path and [...]

The workshop “Maintaining European scientific excellence and global leadership in TB Vaccine R&D EU funded collaborative research and innovation” organised by three H2020 funded projects [...]

Recently the article ‘Insights and challenges in tuberculosis vaccine development’ by Prof. Helen McShane was published in The Lancet.

The VALIDATE Network has a vacancy for a Postdoctoral Bioinformatician/Computational Biologist, based at the Jenner Institute at Oxford University. VALIDATE is an international network of [...]

Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants First trial of a new live attenuated Mycobacterium tuberculosis [...]